Adolph J. Ferro, Ph.D., Chairman

Dr. Ferro is Chief Executive Officer of Artielle Therapeutics and was Chairman, President and CEO of Agritope, Inc. from 1989 to 2000 when Agritope was sold to Exelixis, Inc. Agritope, now named Exelixis Plant Sciences, is an agricultural genomics and biotechnology company. Dr. Ferro was President, CEO and a director of Epitope, Inc. from 1990 through 1998, when Agritope was spun off from Epitope. Epitope, now doing business as OraSure Technologies, is a medical diagnostics company with several FDA approved products. Prior to joining Epitope, Dr. Ferro was a Professor of Microbiology at Oregon State University and is the author of numerous medical and agricultural publications. Dr. Ferro received a B.S. degree in zoology from the University of Washington and a Ph.D. in microbiology from Washington State University.